The Times
.

More Articles ...

  1. Rising Healthcare Costs and Chronic Health Risks Highlight Need for Preventive Care, Alpro Introduces CarePass
  2. Kenanga Investors Group Secures Wins at IFN Investor Awards 2025
  3. Genetron Introduces Regional "Deminars" to Bridge the Gap Between Test Theory and Real-World Application
  4. Arrow Electronics Addresses Rising Autonomous Mobile Robot Demand in Southeast Asia with System-Level Solutions
  5. FPG Fortune Prime Global Marks 15th Anniversary
  6. HKUST 2nd AI Film Festival Concludes Successfully Showcasing Global Excellence in AI Creativity
  7. CoolThink@JC – The 10th Hong Kong Primary School Computational Thinking Competition Grand Final & Awards Presentation Ceremony
  8. Singapore’s Gardens by the Bay Unveils Two New Disney-Themed Experiences For Families
  9. SIWW2026 Water Expo opens visitor registration, showcasing global innovations for a resilient water future
  10. Philanthropy Deployed as Risk Capital Holds Potential to Scale Early-Stage Innovations in Asia, New Report Finds
  11. Beyond the Hype: AI+ Power 2026 Explores How AI Drives Real Business Value
  12. Siam Piwat Joins Forces with Bangkok Pride and National Partners to Launch "The Celebration: Right to Love 2026," Positioning Bangkok as a Global Pride Destination Ahead of Bangkok World Pride 2030
  13. CK Life Sciences’ Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
  14. Fuutura launches non-custodial multi-asset trading protocol with identity attestation at the protocol layer
  15. Doremi3babies Helps Hong Kong Parents Choose the Right Caraz Playmat Size Amid Limited Living Space
  16. V-GREEN Partners With Local Authorities And Businesses In The Philippines To Advance Large-Scale EV Infrastructure
  17. Bupa Hong Kong Launches "Bupa Care Bridge", an Affordable Health Insurance Solution Designed for Cross‑border Living
  18. Sangfor Technologies Leads Next-Generation VMware Alternatives Conversation at Executive Forum 2026 in Bangkok
  19. The 2026 VinFuture Prize Receives More Than 1,800 Nominations as Its Global Nomination Network Expands Fourteenfold After Six Years
  20. Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy